Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | MITF | O75030 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | STAT3 | P40763 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21765862 | 0.87 | MEN1 (0.54) | ALDH1A1MEN1KMT2AMITFPOLB | |
| SCHEMBL30493065 | 0.87 | MEN1 (0.43) | CA12CA2CA9ALDH1A1CYP1A2 | |
| SCHEMBL18784389 | 0.84 | ALDH1A1 (0.50) | CA12CA2CA9ALDH1A1CYP1A2 | |
| SCHEMBL12263890 | 0.83 | ALDH1A1 (0.70) | ALDH1A1MEN1KMT2AFFAR1HPGD | |
| SCHEMBL17475956 | 0.82 | MAPT (0.62) | ALDH1A1MEN1KMT2APOLBGAA | |
| SCHEMBL2843886 | 0.82 | CA12 (0.56) | CA12CA2CA9ALDH1A1CYP1A2 | |
| SCHEMBL9912437 | 0.82 | CA12 (0.56) | CA12CA2CA9ALDH1A1CYP1A2 | |
| SCHEMBL2688879 | 0.81 | EPHX2 (0.61) | ALDH1A1CYP1A2CYP2C9MEN1KMT2A | |
| SCHEMBL9514416 | 0.81 | CA2 (0.48) | CA2ALDH1A1MEN1KMT2ACA1 | |
| SCHEMBL6691641 | 0.80 | MITF (0.55) | CA12CA2CA9ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2494 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4393515-A1 | ANTI-CLDN-18.2 ANTIBODY-DRUG CONJUGATE AND USE THEREOF | Shanghai Junshi Biosciences Co., Ltd. (CN) | 2024-07-03 | — | — | EP | claimed |
| US-12024565-B2 | Targeted CD73 antibody and antibody-drug conjugate, and preparation method therefor and uses thereof | FUDAN UNIVERSITY (CN) | 2024-07-02 | — | — | US | claimed |
| EP-4386006-A1 | ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF | Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (CN) | 2024-06-19 | — | — | EP | claimed |
| US-20240156978-A1 | MAYTANSINE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | ANGIEX, INC. | 2024-05-16 | — | — | US | claimed |
| WO-2024103007-A1 | METHODS FOR DETECTING RNA AND MOLECULAR ANALYSIS IN THICK TISSUE SECTIONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-05-16 | — | — | WO | claimed |
| EP-3218410-B1 | ANTIBODY DRUG CONJUGATES | NOVARTIS AG (CH) | 2024-03-27 | — | — | EP | claimed |
| EP-3965887-B1 | ANTIMICROBIAL CHITOSAN | UNIV GENEVE (CH) | 2024-02-28 | — | — | EP | claimed |
| US-20240043512-A1 | EPITOPES OF ANTI-SERINE PROTEASE INHIBITOR KAZAL (SPIK) ANTIBODIES | IMCARE BIOTECH LLC | 2024-02-08 | — | — | US | claimed |
| EP-4313009-A1 | MAYTANSINE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| US-20230372518-A1 | ANTIMITOTIC TETRAPEPTIDE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | ANGIEX, INC. | 2023-11-23 | — | — | US | claimed |
| US-5399501-A | Covalent attachment of specific binding members to a solid phase with two bifunctional reagents and a dithio compound | ABBOTT LABORATORIES (US) | 1995-03-21 | — | — | US | claimed |
| WO-1994029333-A1 | IMMUNOREACTIVE REAGENTS EMPLOYING MONOAMINE OXIDASE | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-12-22 | — | — | WO | claimed |
| WO-1994020523-A1 | TUMOR TARGETING WITH L-ENANTIOMERIC OLIGONUCLEOTIDE CONJUGATES OF IMMUNOREAGENTS AND OF CHELATED RADIONUCLIDES | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-09-15 | — | — | WO | claimed |
| WO-1994013327-A1 | IMMUNOREACTIVE REAGENTS EMPLOYING DIHYDROFOLATE REDUCTASE | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-06-23 | — | — | WO | claimed |
| WO-1994012216-A1 | SEQUENTIAL TARGETING OF TUMOR SITES WITH OLIGONUCLEOTIDE CONJUGATES OF ANTIBODY AND COMPLEMENTARY OLIGONUCLEOTIDE CONJUGATES OF CHELATED RADIONUCLIDE | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-06-09 | — | — | WO | claimed |
| EP-0366770-B1 | LIPOSOMES COUPLED TO HORMONES | VESTAR INC (US) | 1994-02-09 | — | — | EP | claimed |
| EP-0196669-B1 | IMPROVED METHOD OF CONJUGATING METALLOTHIONEIN TO BIOLOGICALLY ACTIVE MOLECULES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-02-12 | — | — | EP | claimed |
| EP-0396116-A2 | Covalent attachment of specific binding members to a solid phase | ABBOTT LABORATORIES (US) | 1990-11-07 | — | — | EP | claimed |
| US-4657853-A | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-14 | — | — | US | claimed |
| EP-0175560-A2 | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-03-26 | — | — | EP | claimed |